Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
AGMB · NASDAQ · Biological Products, (No Diagnostic Substances) · Foreign private issuer
Agomab Therapeutics (AGMB) · oqro.io/stocks/AGMB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$5.45−0.17 (−3.02%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Director purchased ~$28K of AGMB shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Director purchased ~$30K of AGMB shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Director purchased ~$29K of AGMB shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Director purchased ~$30K of AGMB shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Director purchased ~$120 of AGMB shares in the open marketSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Redmile Group, LLC cut its AGMB stake below 5% (3.5%)SourceInsider trade · Traded Nov 5, 2026 · Filed Nov 6, 2026
Director purchased ~$34K of AGMB shares in the open marketSourceInsider trade · Traded Nov 5, 2026 · Filed Nov 6, 2026
Director purchased ~$35K of AGMB shares in the open marketSourceInsider trade · Traded Nov 5, 2026 · Filed Nov 6, 2026
Director purchased ~$35K of AGMB shares in the open marketSourceInsider trade · Traded Oct 21, 2026 · Filed Oct 22, 2026
Director purchased ~$44K of AGMB shares in the open marketSourceInsider trade · Traded Oct 21, 2026 · Filed Oct 22, 2026
Director purchased ~$45K of AGMB shares in the open marketSourceInsider trade · Traded Oct 8, 2026 · Filed Oct 9, 2026
Director purchased ~$45K of AGMB shares in the open marketSourceInsider trade · Traded Oct 5, 2026 · Filed Oct 7, 2026
CEO purchased ~$51K of AGMB shares in the open marketSourceInsider trade · Traded Oct 6, 2026 · Filed Oct 7, 2026
CEO purchased ~$44K of AGMB shares in the open marketSourceInsider trade · Traded Oct 6, 2026 · Filed Oct 7, 2026
CFO purchased ~$43K of AGMB shares in the open marketSourceInsider trade · Traded Oct 6, 2026 · Filed Oct 7, 2026
Director purchased ~$44K of AGMB shares in the open marketSourceInsider trade · Traded Oct 6, 2026 · Filed Oct 7, 2026
CFO purchased ~$17K of AGMB shares in the open marketSourceInsider trade · Traded Oct 6, 2026 · Filed Oct 7, 2026
CFO purchased ~$26K of AGMB shares in the open marketSourceInsider trade · Traded Oct 5, 2026 · Filed Oct 7, 2026
Director purchased ~$43K of AGMB shares in the open marketSource